Current research projects include laboratory and patient-oriented projects aimed at understanding and treating diabetes. Particular areas of interest include the pathogenesis of Type 1 and Type 2 diabetes, the regulation of glucose metabolism and the regulation of bone growth and development. These research projects receive funding from the NIH as well as from pharmaceutical sponsors.
The Vanderbilt Eskind Pediatric Diabetes Clinic also participates in the Type 1 Diabetes TrialNet, an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.
TrialNet is conducting clinical trials with researchers from 18 Clinical Centers in the United States, Canada, Finland, United Kingdom, Italy, Germany, Australia and New Zealand. In addition, more than 150 medical centers and physician offices are participating in the TrialNet network.
Studies are available for people newly diagnosed with type 1 diabetes, as well as for relatives of people with type 1 diabetes who are at greater risk of developing the disease.
To learn more about the wide variety of ongoing diabetes research at Vanderbilt, visit the Vanderbilt Diabetes Research and Training Center website.
Vanderbilt®, Vanderbilt University Medical Center®, V Oak Leaf Design®,
Monroe Carell Jr. Children's Hospital at Vanderbilt®, and Vanderbilt Health®
are all trademarks of The Vanderbilt University.
© 2017 Vanderbilt University Medical Center. All rights reserved.